| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.08. | Sona Nanotech Inc: Sona Nanotech closes $2.52-million private placement | 1 | Stockwatch | ||
| 11.08. | Sona Nanotech Closes Over-Subscribed Private Placement Financing to Raise $2,527,012 in Gross Proceeds | 1 | CNW | ||
| SONA NANOTECH Aktie jetzt für 0€ handeln | |||||
| 31.07. | Sona Nanotech Inc: Sona Nanotech arranges $2.4-million private placement | 1 | Stockwatch | ||
| 31.07. | Sona Nanotech To Arrange Private Placement Financing | 1 | CNW | ||
| 11.06. | Sona Nanotech Inc: Sona Nanotech appoints Fleming director | 1 | Stockwatch | ||
| 11.06. | Sona Nanotech Appoints Seasoned Biotech Commercial Executive Michael A. Fleming to Board of Directors | 1 | CNW | ||
| 05.05. | Sona Nanotech Announces Clinical Strategy With Two THT Combination Therapy Studies In Melanoma | 4 | CNW | ||
| 27.04. | Sona Nanotech Showcases Cancer Therapy Results At Prestigious Industry Cancer Conferences | 1 | CNW | ||
| 16.04. | Sona Nanotech Inc: Sona Nanotech appoints Smylie, Trites to advisory board | 1 | Stockwatch | ||
| 16.04. | Sona Nanotech Announces Appointment of Two Leading Oncologists To Its Scientific Advisory Board | 1 | CNW | ||
| 13.04. | Sona Nanotech Inc: Sona Nanotech upbeat about THT's effect on tumours | 2 | Stockwatch | ||
| 13.04. | Sona Nanotech Clinical Cancer Study Tissue Analysis Confirms Tumor Priming And Suggests Potential Immunotherapy Synergies | 2 | CNW | ||
| 08.04. | Sona Nanotech Inc: Sona says THT shows strong combo cancer efficacy | 3 | Stockwatch | ||
| 07.04. | Sona Nanotech's THT Cancer Therapy Demonstrates Strong Efficacy And Durability In Combination with Immunotherapy In Peer-reviewed Preclinical Study | 1 | CNW | ||
| 20.10.25 | Sona Nanotech Inc.: Sona Nanotech Reports 80% Response Rate in First-In-Human THT Cancer Therapy Study | 815 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - October 20, 2025) - Sona Nanotech Inc., (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), is pleased to announce the completion of its first-in-human clinical... ► Artikel lesen | |
| 17.10.25 | Sona Nanotech Inc.: Sona Nanotech To Host Investor Webinar To Discuss Clinical Study | 1.380 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - October 17, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), announces that it will host a webinar on Monday, October 20th at noon... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 19,000 | -2,36 % | EQS-News: Formycon AG: Formycon setzt Maßstäbe in der Biosimilar-Entwicklung: Wissenschaftliche Grundlagen des innovativen Entwicklungsprogramms für FYB206 im Fachjournal BioDrugs veröffentlicht | EQS-News: Formycon AG
/ Schlagwort(e): Wissenschaftl. Publikation
Formycon setzt Maßstäbe in der Biosimilar-Entwicklung: Wissenschaftliche Grundlagen des innovativen Entwicklungsprogramms... ► Artikel lesen | |
| OBDUCAT | 0,038 | 0,00 % | NGM MARKET NOTICE: #26-72 Decision by the Disciplinary Committee regarding Obducat AB (publ) | ||
| ONTO INNOVATION | 246,30 | -2,49 % | $1000 Invested In Onto Innovation 10 Years Ago Would Be Worth This Much Today | ||
| GAUZY | 5,310 | 0,00 % | GAUZY LTD: Gauzy Announces Receipt of Delisting Notice from Nasdaq; Intends to Appeal | TEL AVIV, Israel, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Gauzy Ltd. (Nasdaq: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control technologies, today announced receipt of a delisting... ► Artikel lesen | |
| VEECO INSTRUMENTS | 43,460 | -0,32 % | Veeco Instruments pushes higher by 9%, adding to recent upswing | ||
| GOMSPACE | 0,993 | -0,50 % | GOMSPACE GROUP AB: GomSpace joins ESA-funded study for future Arctic satellite constellation supporting secure maritime communication | ||
| SOLESENCE | 0,830 | 0,00 % | Solésence, Inc.: Solésence Reports Second Quarter 2026 Financial Results | Quarterly Report Filed on Form 10-Q Company to Host Conference Call at 5:00 p.m. ET Today ROMEOVILLE, Ill., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically... ► Artikel lesen | |
| KOPIN | 4,272 | 0,00 % | Stifel reiterates Kopin stock Buy rating on drone demand outlook | ||
| ACACIA RESEARCH | 3,660 | -1,08 % | ACACIA RESEARCH CORP - 10-Q, Quarterly Report | ||
| ADVANCE ZINCTEK | 0,342 | -3,93 % | Advance Zinctek Ltd Profit Advances In Full Year | ||
| LAMPETIA | 0,156 | 0,00 % | EQS-Adhoc: Lampetia AG: Einigung über die Beendigung von Rechtsstreitigkeiten | EQS-Ad-hoc: Lampetia AG / Schlagwort(e): Sonstiges
Lampetia AG: Einigung über die Beendigung von Rechtsstreitigkeiten
16.07.2026 / 22:00 CET/CEST
Veröffentlichung einer Insiderinformation... ► Artikel lesen | |
| RIBER | 9,050 | 0,00 % | Riber Reports Improved Results For The First Half Of 2026 |
RIBER REPORTS IMPROVED RESULTS FOR THE FIRST HALF OF 2026 Revenues of €12.7m (+19%) and gross margin of €5.1m (+31%), representing 39.8% of revenuesPositive net income of €0.2m, compared with -€0.8m... ► Artikel lesen | |
| ANTEOTECH | 0,003 | 0,00 % | ANTEOTECH LTD: FY2026 Corporate Governance Statement and Appendix 4G | ||
| ZENTEK | 0,452 | -1,31 % | Zentek Ltd.: Zentek Files Technical Report for the Albany Graphite PEA: US$3.85 Billion After-Tax NPV at a 5% Discount Rate, 27.4% After-Tax IRR, on an Acid-Free Route to Ultra-High-Purity Graphite | Initial capital of US$817 million, after-tax payback of 4.4 years and a 30-year production period. Micon recommends advancing Albany to a Pre-Feasibility Study.Filed on SEDAR+ on September 24, 2026... ► Artikel lesen | |
| REGION GROUP | 1,318 | +0,92 % | REGION GROUP: Change of Director's Interest Notice |